本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Maravai LifeSciences Holdings, Inc.

6.53
-0.2000-2.97%
盤後6.53-0.0032-0.05%19:59 EDT
成交量:326.40萬
成交額:2,148.24萬
市值:16.96億
市盈率:-12.32
高:6.91
開:6.84
低:6.49
收:6.73
52周最高:9.42
52周最低:2.55
股本:2.60億
流通股本:1.03億
量比:1.33
換手率:3.17%
股息:- -
股息率:- -
每股收益(TTM):-0.5299
每股收益(LYR):-0.9059
淨資產收益率:-33.05%
總資產收益率:-5.71%
市淨率:8.29
市盈率(LYR):-7.21

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/23

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2025/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report